http://www.marksdailyapple.com/jama-vioxx-spoof/ Serving up health and fitness insights (daily, of course) with a side of irreverence. Sat, 21 Nov 2009 09:49:33 -0700 http://wordpress.org/?v=2.8.1 hourly 1 http://www.marksdailyapple.com/jama-vioxx-spoof/#comment-1703 Mark’s Daily Apple » Blog Archive » The Trouble with Cured Meats Mon, 16 Apr 2007 22:12:47 +0000 http://www.marksdailyapple.com/jama-vioxx-spoof/#comment-1703 [...] Bad Science’s Ben Goldacre examines the Big Pharma study-skewing controversy. In a nutshell: yes, they skew; but so does everybody. (Wait, is that supposed to make us feel good?) The article is excellent, so if you care about the future of drugs in medicine, or just really have a problem with Big Pharma, be sure to read it. In particular, we want to highlight the excellent idea for removing publication bias (the biggest problem, bar none, with the whole pharmacological picnic). Goldacre suggests that all trials, no matter the perceived utility, be reported in a public database of some sort. In other words, trials should be recorded from the start, not simply because they’re deemed worth publishing in hindsight. It’s one of those “uh, duh!” ideas that is so smart, so obvious, and so sensible, we are left to conclude that absence of said database = world has gone mad. (Check out Mark’s article on Big Pharma.) [...] [...] Bad Science’s Ben Goldacre examines the Big Pharma study-skewing controversy. In a nutshell: yes, they skew; but so does everybody. (Wait, is that supposed to make us feel good?) The article is excellent, so if you care about the future of drugs in medicine, or just really have a problem with Big Pharma, be sure to read it. In particular, we want to highlight the excellent idea for removing publication bias (the biggest problem, bar none, with the whole pharmacological picnic). Goldacre suggests that all trials, no matter the perceived utility, be reported in a public database of some sort. In other words, trials should be recorded from the start, not simply because they’re deemed worth publishing in hindsight. It’s one of those “uh, duh!” ideas that is so smart, so obvious, and so sensible, we are left to conclude that absence of said database = world has gone mad. (Check out Mark’s article on Big Pharma.) [...]

]]>